Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Gilead Sciences Ltd
Flowers Building, Granta Park, Abington, Cambridge, Cambridge, CB21 6GT, UK
Telephone: +44 (0)1223 897 300
Fax: +44 (0)1223 897 291
Medical Information Direct Line: +44 (0)1223 897 555
Medical Information e-mail: ukmedinfo@gilead.com
Customer Care direct line: +44 (0)1223 897 400
Medical Information Fax: +44 (0)1223 897 281

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 03/01/2012
PIL Hepsera 10 mg tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 03/01/2012 and displayed until Current
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Change due to harmonisation of PIL.
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to information about pregnancy or lactation
Updated on 23/02/2009 and displayed until 03/01/2012
Reasons for adding or updating:
  • Change to Further Information section
  • Change to warnings or special precautions for use
Updated on 19/01/2009 and displayed until 23/02/2009
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
Updated on 19/09/2008 and displayed until 19/01/2009
Reasons for adding or updating:
  • Change to date of revision
Updated on 15/05/2008 and displayed until 19/09/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 29/04/2008 and displayed until 15/05/2008
Reasons for adding or updating:
  • Change to side-effects
  • Change to warnings or special precautions for use
Updated on 19/12/2007 and displayed until 29/04/2008
Reasons for adding or updating:
  • Change to MA holder contact details
  • Change due to user-testing of patient information
Updated on 13/09/2007 and displayed until 19/12/2007
Reasons for adding or updating:
  • Change to Further Information section
Updated on 27/09/2006 and displayed until 13/09/2007
Reasons for adding or updating:
  • Change to side-effects
Updated on 01/09/2006 and displayed until 27/09/2006
Reasons for adding or updating:
  • Change to Further Information section
Updated on 05/05/2006 and displayed until 01/09/2006
Reasons for adding or updating:
  • Change to side-effects
Updated on 22/11/2005 and displayed until 05/05/2006
Reasons for adding or updating:
  • Change to side-effects
Updated on 07/06/2005 and displayed until 22/11/2005
Reasons for adding or updating:
  • Change to Further Information section
Updated on 15/09/2004 and displayed until 07/06/2005
Reasons for adding or updating:
  • Change to Further Information section
Updated on 13/06/2003 and displayed until 15/09/2004
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  adefovir dipivoxil